| Autor: |
A, Dispenzieri, A, D'Souza, M A, Gertz, K, Laumann, G, Wiseman, M Q, Lacy, B, LaPlant, F, Buadi, S R, Hayman, S K, Kumar, D, Dingli, W J, Hogan, S M, Ansell, D A, Gastineau, D J, Inwards, I N, Micallef, L F, Porrata, P B, Johnston, M R, Litzow, T E, Witzig |
| Rok vydání: |
2016 |
| Předmět: |
|
| Zdroj: |
Bone marrow transplantation. 52(10) |
| ISSN: |
1476-5365 |
| Popis: |
This phase 1 study (clinical trial NCT00477815) was conducted to determine the maximum tolerated dose (MTD) of yttrium-90 ibritumomab tiuxetan ( |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink